15th International Society for Prenatal Diagnosis Meeting

描述（由申请人提供）：摘要我们请求部分财政支持，以支付与国际产前诊断学会（ISPD），将于2010年7月11日至14日在荷兰阿姆斯特丹举行的第15次会议相关的演讲者差旅费。ISPD是一个独特的多学科协会，包括产科医生，母胎医学专家，儿科医生，临床遗传学家，实验室遗传学家，遗传咨询师，胎儿外科医生，研究人员，社会科学家和伦理学家，他们在产前诊断领域工作。ISPD每两年在不同地点举行一次会议，以鼓励不同的参与者。2010年的科学计划包括31位国际知名的特邀演讲者和8位思想领袖，他们将在该领域内讨论4个不同的及时主题。100%的受邀演讲者接受了参加会议的邀请，这一事实证明了与会者的热情。此外，将接受提交的摘要中的口头和海报介绍。最先进的辩论将使与会者了解当前的争议领域。这些问题包括干细胞疗法是否已为人类胎儿做好准备，行业赞助是否加速或阻碍了研究的步伐，常规核型分析在后阵列CGH时代是否有必要，以及超声是否比母体血液中的无细胞胎儿核酸更适合唐氏综合征筛查。作为参加ISPD会议的结果，与会者将接触到广泛的当前主题，这些主题将直接影响他们的临床实践，并将创建新的研究议程。与会者的多学科主题和不同背景将导致活跃的科学交流和创造性思维。会议的创新方面包括对有争议领域的辩论，对产业在产前诊断研究中的作用的坦率讨论，以及由产前诊断领域领先专家提出的免费下载的节目后播客摘要。 公共卫生相关性：产前诊断的目标是向孕妇及其伴侣提供信息，使他们能够建立健康的家庭。产前诊断也为提供胎儿治疗提供了机会。本次会议的目标是告知和促进临床医生，科学家，非医生医疗保健提供者，临床实验室主任和社会科学家之间关于这一学科工作的讨论。作为会议的结果，与会者将能够确定目前的做法和知识的局限性和差距，并制定一个研究议程前进。

DESCRIPTION (provided by applicant): Abstract We are requesting partial financial support to defray speaker travel expenses associated with the 15th meeting of the International Society for Prenatal Diagnosis (ISPD), to be held July 11-14, 2010, in Amsterdam, the Netherlands. The ISPD is a unique, multidisciplinary society that includes obstetricians, maternal-fetal medicine specialists, pediatricians, clinical geneticists, laboratory-based geneticists, genetic counselors, fetal surgeons, researchers, social scientists, and ethicists who work within the discipline of prenatal diagnosis. The ISPD meets every 2 years in different locations to encourage diverse attendance. The 2010 Scientific Program includes 31 internationally renowned invited speakers, and 8 thought leaders who will debate 4 different timely topics within the field. Enthusiasm for the conference is evidenced by the fact that 100% of the invited speakers accepted the invitation to participate. In addition, oral and poster presentations will be accepted from submitted abstracts. State-of the-art debates will inform participants about current areas of controversy. These include whether stem cell therapy is ready for human fetuses, whether industry sponsorship accelerates or hinders the pace of research, whether conventional karyotyping is necessary in the post-array-CGH era, and whether ultrasound is better for Down syndrome screening than cell-free fetal nucleic acids in maternal blood. As a result of attending the ISPD conference participants will be exposed to a wide-range of current topics that will directly affect their clinical practice and will create new research agendas. The multidisciplinary topics and varied backgrounds of the attendees will lead to lively scientific interchange and creative thinking. Innovative aspects of the meeting include the debates regarding controversial areas, a frank discussion of the role of industry in prenatal diagnosis research, and a free downloadable post-program podcast summary presented by leading experts in prenatal diagnosis. PUBLIC HEALTH RELEVANCE: The goal of prenatal diagnosis is to provide pregnant women and their partners with information that allows them to build healthy families. Prenatal diagnosis also allows an opportunity to provide fetal therapy. The goal of this conference is to inform and promote discussions between clinicians, scientists, non-physician health care providers, clinical laboratory directors, and social scientists regarding work in this discipline. As a result of the conference, participants will be able to identify limitations and gaps in current practice and knowledge and develop a research agenda going forward.